{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-030203","form_type":"8-K","ticker":"FDMT","cik":"0001650648","company_name":"4D Molecular Therapeutics, Inc.","filed_at":"2024-02-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.979565+00:00","generated_at":"2026-06-06T04:51:37.026861+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"4D Molecular Therapeutics raises ~$281.4M in public offering of common stock and pre-funded warrants","bullets":["Sold 6,586,015 shares at $29.50/share and pre-funded warrants for 3,583,476 shares at $29.4999 each.","Underwriters granted 30-day option to purchase up to 1,525,423 additional shares.","Net proceeds ~$281.4M after underwriting discounts and expenses; offering closed Feb 9, 2024.","Directors and officers subject to lock-up until April 6, 2024 without underwriter consent."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-030203","json":"https://secwatch.observer/filing/0001193125-24-030203.json","markdown":"https://secwatch.observer/filing/0001193125-24-030203.md","text":"https://secwatch.observer/filing/0001193125-24-030203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1650648/000119312524030203/0001193125-24-030203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1650648/000119312524030203/d185041d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:51:37.026861+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}